KRS 315.038: Definitions for section -- Ambulatory pharmacies -- Reporting

requirements -- Data to be shared with commissioner of insurance -- Contract

with third-party to collect or process data.

(1) As used in this section:

(a) "Ambulatory pharmacy" has the same meaning as in KRS 304.17A-595; and

(b) "Commissioner" means the commissioner of the Department of Insurance.

(2) An ambulatory pharmacy located in Kentucky and permitted under this chapter

shall, by March 1, 2026, and by March 1 every other year thereafter, provide data to

the board, in accordance with the requirements of KRS 304.17A -595 and

subsection (3) of this section, relating to the pharmacy's dispensing costs for the

previous calendar year.

(3) The board shall promulgate an administrative r egulation in accordance with KRS

Chapter 13A to implement and effectuate subsection (2) of this section, which shall

include:

(a) Incorporating the data elements to be collected from each pharmacy, as

determined by the commissioner under KRS 304.17A-595(2)(c)2.c.i.; and

(b) Establishing the reporting format, and the manner, of the data submission.

(4) The data collected by the board under this section shall, within thirty (30) days of

receipt, be shared with the commissioner for the purposes set forth in KR S

304.17A-595(2)(c)2.

(5) In carrying out its duties under this section, the board shall cooperate and consult

with the commissioner.

(6) All information and data acquired by the board or the commissioner under this

section or KRS 304.17A-595 shall:

(a) Be deemed, and protected as, confidential and proprietary; and

(b) Not be subject to disclosure under KRS 61.870 to 61.884.

(7) The board or the commissioner may retain or contract with one (1) or more third -

party vendors or contractors to collect or proce ss the data required under this

section, or provide any other expertise, service, or function necessary to carry out

the board's or commissioner's duties under this section or KRS 304.17A -595, if the

vendor or contractor:

(a) Agrees in a written or electro nic record to maintain the confidential and

proprietary status of the data and all information relating to the data; and

(b) Is not owned by or affiliated with a pharmacy benefit manager, as defined in

KRS 304.9-020.